Compare ONCO & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONCO | ORIS |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 3.7M |
| IPO Year | 2022 | 2024 |
| Metric | ONCO | ORIS |
|---|---|---|
| Price | $1.65 | $1.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 55.1K | ★ 532.2K |
| Earning Date | 11-13-2025 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $1,223,751.00 | ★ $12,317,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $181.14 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.37 | $1.11 |
| 52 Week High | $88.40 | $57.00 |
| Indicator | ONCO | ORIS |
|---|---|---|
| Relative Strength Index (RSI) | 37.01 | 85.15 |
| Support Level | $1.37 | $1.11 |
| Resistance Level | $1.71 | $1.76 |
| Average True Range (ATR) | 0.18 | 0.08 |
| MACD | 0.00 | 0.15 |
| Stochastic Oscillator | 28.00 | 75.16 |
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).